CRISPR Therapeutics
CRSP
#3196
Rank
S$5.14 B
Marketcap
$60.23
Share price
0.88%
Change (1 day)
-26.43%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2023 (TTM): -$7.32

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is -$7.15. In 2022 the company made an earnings per share (EPS) of -$11.29 a decrease over its 2021 EPS that were of $6.73.

EPS history for CRISPR Therapeutics from 2016 to 2023

201720182019202020212022-$10-$5$5$100companiesmarketcap.com

Annual EPS

Year EPS Change
2023 (TTM)-$7.32-35.24%
2022-$11.29-267.74%
2021$6.73-194.33%
2020-$7.14-576.58%
2019$1.50-132.36%
2018-$4.63100.58%
2017-$2.31159.42%
2016-$0.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.94-58.87%๐Ÿ‡บ๐Ÿ‡ธ USA